Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BOSTON SCIENTIFIC CORP Director's Dealing 2020

Feb 24, 2020

29821_dirs_2020-02-24_9e15c5c9-629c-4d50-968e-b5aa25fbaf16.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2020-02-21

Reporting Person: Butcher Arthur C (EVP&Pres, Asia Pacific)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-02-21 Common Stock M 1713.0000 $0.0000 Acquired 26695.0000 Direct
2020-02-21 Common Stock F 521.0000 $42.6200 Disposed 26174.0000 Direct
2020-02-22 Common Stock M 1014.0000 $0.0000 Acquired 27188.0000 Direct
2020-02-22 Common Stock F 309.0000 $42.6200 Disposed 26879.0000 Direct
2020-02-23 Common Stock M 1073.0000 $0.0000 Acquired 27952.0000 Direct
2020-02-23 Common Stock F 440.0000 $42.6200 Disposed 27512.0000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-02-21 Deferred Stock Units $ M 1713.0000 Disposed 2023-02-21 Common Stock (1713.0000) Direct
2020-02-22 Deferred Stock Units $ M 1014.0000 Disposed 2021-02-22 Common Stock (1014.0000) Direct
2020-02-23 Deferred Stock Units $ M 1073.0000 Disposed 2020-02-23 Common Stock (1073.0000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 2558.0000 Indirect

Footnotes

F1: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F2: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.

F3: Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.

F4: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant.

F5: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.

F6: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant.